Statistical power calculations for mixed pharmacokinetic study designs using a population approach

Statistical power calculations for mixed pharmacokinetic study designs using a population approach

Diğer sürümleri göster (1)

Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approach. To determine the number of individuals required to detect the effect of a covariate, simulation-based power calculation methodologies can be employed. The Monte Carlo Mapped Power method (a simula...

Detaylı Bibliyografya
Asıl Yazarlar:	Kloprogge, F, Simpson, J, Day, N, White, N, Tarning, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Springer New York LLC 2014

Benzer Materyaller

Statistical power calculations for mixed pharmacokinetic study designs using a population approach.
Yazar:: Kloprogge, F, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Yazar:: Kloprogge, F, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.
Yazar:: Kloprogge, F, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
Yazar:: Jamsen, K, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border
Yazar:: Kloprogge, F, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
Yazar:: Kloprogge, F, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
Yazar:: Jamsen, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
Yazar:: Chairat, K, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Towards optimal design of anti-malarial pharmacokinetic studies.
Yazar:: Simpson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
Yazar:: Kloprogge, F
Baskı/Yayın Bilgisi: (2013)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
Yazar:: Chotsiri, P, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications.
Yazar:: Hoglund, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
Yazar:: Wattanakul, T, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
Yazar:: Simpson, J, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Population pharmacokinetic properties of antituberculosis drugs in Vietnamese children with tuberculous meningitis
Yazar:: Panjasawatwong, N, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Population pharmacokinetics of artesunate and amodiaquine in African children.
Yazar:: Stepniewska, K, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
Yazar:: Hoglund, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
Yazar:: Lohy Das, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Pharmacokinetic Properties of Anti-Influenza Neuraminidase Inhibitors.
Yazar:: Chairat, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
Yazar:: Chairat, K, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria.
Yazar:: Hendriksen, I, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

POPULATION PHARMACOKINETICS OF ARTESUNATE AND AMODIAQUINE IN AFRICAN CHILDREN
Yazar:: Stepniewska, K, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Pharmacokinetic considerations in seasonal malaria chemoprevention
Yazar:: Chotsiri, P, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pharmacokinetic interactions between primaquine and chloroquine.
Yazar:: Pukrittayakamee, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)